Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
J Biol Regul Homeost Agents ; 21(3-4): 49-62, 2007.
Article in English | MEDLINE | ID: mdl-18261257

ABSTRACT

CD40 is a member of the growing tumor necrosis factor receptor (TNF-R) family of molecules, and has been shown to play important roles in T cell-mediated B lymphocyte activation. Ligation of B cell CD40 by CD154 expressed on activated T cells stimulates B cell proliferation, differentiation, isotype switching, upregulation of surface molecules contributing to antigen presentation, development of the germinal center, and the humoral memory response. The present review will summarize recent literature data on the various CD40 signalling pathways, which involve both the TNF-R associated factors (TRAFs) and additional signalling proteins, and lead to activation of kinases and transcription factors.


Subject(s)
B-Lymphocytes/physiology , CD40 Antigens/physiology , Lymphocyte Activation/physiology , Signal Transduction , CD40 Antigens/chemistry , DNA-(Apurinic or Apyrimidinic Site) Lyase/physiology , Humans , OX40 Ligand/chemistry , OX40 Ligand/physiology , Paired Box Transcription Factors/physiology , Transcription Factors/physiology , Tumor Necrosis Factor Receptor-Associated Peptides and Proteins/chemistry , Tumor Necrosis Factor Receptor-Associated Peptides and Proteins/physiology
2.
Digestion ; 64(1): 9-14, 2001.
Article in English | MEDLINE | ID: mdl-11549832

ABSTRACT

BACKGROUND/AIM: There is evidence of a possible etiological role of human papillomaviruses (HPVs) in the development of esophageal tumors. Loss of function of the wild-type p53 tumor suppressor gene product by binding to E6 oncoproteins of high-risk HPVs is considered an important event in tumor development. The aim of this study was to verify the prevalence of HPV infection and p53 mutation in esophageal tumor tissue samples and in the adjacent normal mucosa in patients from a high-risk area in Italy. METHODS: DNA from 33 biopsy specimens (17 tumor sample biopsies and 16 samples of adjacent normal mucosa) was screened for HPV DNA using two polymerase chain reaction based procedures. Restriction fragment length polymorphism analysis was used for typing. Screening of p53 mutations was performed with polymerase chain reaction-single strand conformation polymorphism analysis and DNA sequencing. RESULTS: Overall, 8 of 17 patients presented HPV DNA; HPV 16 was detected in 4 of 8 samples. Samples from tumors and adjacent mucosa were positive for mucosal HPVs in 7 of 17 and 4 of 16 cases, respectively. In 1 case, HPV DNA was detected in the normal mucosa only. None of the samples contained HPVs of the epidermodysplasia verruciformis or cutaneous groups. Mutations of p53 were detected in two HPV DNA negative samples. In both cases, the mutation was present in the tumor only. CONCLUSIONS: Our results are in favor of the involvement of both aberrant p53 expression and HPV infection in the development of esophageal tumors. The high HPV infection rate in patients from a high-risk region suggests that subjects harboring HPVs (in particular HPV 16) in the esophagus should be considered at risk of esophageal malignancies.


Subject(s)
Adenocarcinoma/virology , Carcinoma, Squamous Cell/virology , DNA, Viral/analysis , Esophageal Neoplasms/virology , Genes, p53 , Mutation , Papillomaviridae/isolation & purification , Adenocarcinoma/genetics , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/genetics , Esophageal Neoplasms/genetics , Female , Gastric Mucosa/virology , Humans , Italy , Male , Middle Aged , Papillomaviridae/genetics , Polymerase Chain Reaction , Polymorphism, Single-Stranded Conformational
3.
Adv Clin Path ; 4(2): 77-85, 2000 Apr.
Article in English | MEDLINE | ID: mdl-11080787

ABSTRACT

Antibodies have been used therapeutically to treat a variety of clinical conditions. The introduction of monoclonal antibodies (mAb) and, recently, engineered antibodies has greatly refined and expanded the therapeutic potential of this modality of treatment. Expanded use will depend on improvement in their efficacy (affinity and specificity), demonstration of their safety, and reduction of their immunogenicity depending on the size, suboptimal biodistribution and pharmacokinetics. To surmount these problems the molecules have to be redesigned and the basic issues of how monoclonal antibodies kill cells reinvestigated. The review will survey the literature for humanized antibodies in clinical trials and the perspective of the use of mAbs or engineered antibodies in clinical practice.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Immunotherapy , Animals , Antibodies, Monoclonal/immunology , Antibody Specificity , Clinical Trials as Topic , Genetic Engineering , Humans , Immunoglobulin G/chemistry , Immunoglobulin G/immunology , Mice , Protein Engineering , Recombinant Proteins/immunology , Recombinant Proteins/therapeutic use
4.
Immunology ; 98(4): 564-8, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10594689

ABSTRACT

The beta1 integrins are a family of heterodimeric adhesion receptors involved in cell-to-cell contacts and cell-to-extracellular matrix interactions. Through their adhesive role, integrins participate in transduction of outside/inside signals and contribute to trigger a multitude of cellular events such as differentiation, cell activation, and motility. The fibronectin integrin receptors, alpha4beta1 and alpha5beta1, can function as costimulatory molecules in T-cell receptor (TCR)-dependent T-cell activation. In the current study the Jurkat T-cell line was used as a model system to investigate the TCR-independent role of cell adhesion to fibronectin in the activation of Zap-70, a central molecule in the signalling events in T cells. Upon adhesion to plastic immobilized fibronectin but not to bovine serum albumin (BSA) the phosphorylation of p125FAK, a protein kinase that localizes to focal adhesion sites, was induced. Moreover, clustering of fibronectin receptors led to the detection of a p125FAK/Zap-70 complex. Finally, while the complex between fak-B, another protein kinase localized to focal adhesion sites, and Zap-70 was detected in cells plated either on BSA or on fibronectin, the formation of the p125FAK/Zap-70 complex appeared specifically induced following fibronectin-mediated integrin clustering. These data suggest the existence of a high degree of specificity when the members of the beta1 integrin family mediate signalling pathways in T cells.


Subject(s)
Cell Adhesion Molecules/metabolism , Fibronectins/physiology , Protein-Tyrosine Kinases/metabolism , Receptors, Antigen, T-Cell/metabolism , Signal Transduction , T-Lymphocytes/immunology , Cell Adhesion , Focal Adhesion Kinase 1 , Focal Adhesion Protein-Tyrosine Kinases , Humans , Immunoblotting , Jurkat Cells , Phosphorylation , Receptor, Insulin/metabolism , Tyrosine/metabolism , ZAP-70 Protein-Tyrosine Kinase
SELECTION OF CITATIONS
SEARCH DETAIL